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A SYMPOSIUM: SOME LEGAL PROBLEIS IN
MEDICAL TREATMENT AND RESEARCH
A PHYSICIAN'S VIEW OF INFORMED CONSENT
IN HUMAN EXPERIMENTATION
R. E. RITTS, JR., M.D.*
We cannot conceive what the nature of the instrument made use of is:
why did Baker put it on, when he said that plaintiff had fallen into good
hands, and when plaintiff only sent for him to take off the bandage? It seems
as if Mr. Baker wanted to try an experiment with this new instrument.
... [1]t appears from the evidence of the surgeons that it was improper
to disunite the callous without consent; this is the usage and law of surgeons:
then it was ignorance and unskilfulness in that very particular, to do con-
trary to the rule of the profession, what no surgeon ought to have done; and
indeed it is reasonable that a patient should be told what is about to be done
to him, that he may take courage and put himself in such a situation as to
enable him to undergo the operation. . . . IT]his was the first experiment
made with this new instrument; and if it was, it was a rash action, and he
who acts rashly acts ignorantly: and although the defendants in general may
be as skilful in their respective professions as any two gentlemen in England,
yet the Court cannot help saying, that in this particular case they have
acted ignorantly and unskilfully, contrary to the known rule and usage of
surgeons.
Judgment for the plaintiff per totam Curiam.1
"'INFO D consent" by subjects of biomedical investigations poses a
more complex matter in practice than in discussions such as this one.
Professor Smith elsewhere in this issue has lucidly reviewed the various
codes and mechanisms used by investigators in human experimentation.
Reference will be made to these codes in this discussion without repeating
them in toto.
It is appropriate to address attention to the semantics of the problem,
if only to dismiss this parameter. In medical circles there are occasional
grumblings that the responsibility to "inform" the subjects is either
unreasonable or impossible. If the investigator were able accurately to
inform the participant of all the eventualities which might take place
during the course of the proposed study, there would be no need for
him to conduct an investigation. In fact, even if he did, it would not be
* Head, Section of Microbiology, Mayo Clinic, Rochester, Minnesota. Professor of
Microbiology, Mayo Graduate School, University of Minnesota. A portion of this article
was presented at the American Academy of Arts and Sciences Conference on The Ethical
Aspects of Experimentation on Human Subjects. Cambridge, Massachusetts, November 3
and 4, 1967.
1. Slater v. Baker, 95 Eng. Rep. 860, 862 (K.B. 1767).
2. See p. 673 infra.
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an experiment. Taken to its captious extreme this posture is patently
true. As our colleagues in the law are notable for making relevant defini-
tions, let me admit at once that if the investigator could be completely
"informed," the reason for experimentation would cease to exist. To
insist upon this stance or even to be sympathetic to it is to beg the
question and fail to discuss the issues cogently. Some attorneys have
preferred the more meaningful ring of "legally effective consent," others
opt for "complete disclosure." To avoid this barren approach, it is sub-
mitted that "consent" or "informed consent" means the patient-subject
has agreed to participate in a biomedical experiment under the direction
of a physician responsible for his physical and mental health and that
his agreement has been given after he understands what procedures will
be performed on him, the possible risks and benefits as far as can be
predicted on the basis of available knowledge and that he is always privi-
ledged to withdraw from the study consonant with his own safety. This
is, perhaps, a more stylized and rigid consent than many investigators
or types of experiment can tolerate. It is apparent that there are degrees
of consent ranging from the above to a casual verbal permission to "do
whatever you want." One analysis based on the degree of "rights" sur-
rendered by the participant as well as a categorization of the types of
research has recently appeared.' Other than articulating some of the
issues, I am uncertain that the degrees of consent are as meaningful as
the possible risks inherent in a given experiment and the need (as op-
posed to desirability) to perform the specific experiment.
There are two major premises that most physician-investigators em-
brace in the course of their studies. Indeed, these premises are in the
nature of rubrics. The first principle is that science and humanity demand
the participation of humans as subjects for medical experimentation.
In the main, there are two areas in which human studies are essential.
The first situation occurs where the species differentiation between man
and other animals is so pronounced that to study lower animals exclu-
sively is usually fruitless to understand human biology. This is especially
so in the manifestations of central nervous system mechanisms, including
attitudinal and behavioral characteristics. The second situation in which
only man suffices as the subject relates to the cause, natural history,
prevention and treatment of human diseases. Because of species specifi-
city, environmental factors and often the uniqueness of the infecting or
sensitizing agent in infectious or immunological disease states, the unique-
ness of man and the uniqueness of the resulting interaction demand that
only man can serve.
The second major premise is that the conditions and circumstance of
the particular experiment are merely extensions of the usual patient-
physician relationship. However, rather than abrogating the ethical and
3. Wolfensberger, Ethical Issues in Research with Human Subjects, 155 Science 47
(1967).
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moral principles implicit in such a relationship, the conditions of the cir-
cumstances and motivations of all the participants should enhance these
principles, provided the subject has a clear understanding of the experi-
ment and his role in it.
This author is aware that from a legal standpoint there are objections
to this statement since there are no specific rules of liability dealing with
clinical investigation.4 Indeed, the body of opinion in the courts is to the
effect that a physician is measured judicially by the conduct of his peers
and standards of practice in the community in which he practices.'
Further, as the subject's physician, he is regarded by the courts to be in
a special position of trust and confidence." It is incumbent upon him not
only to inform his patient of the experimental procedures, but, because
of this special relationship, to ensure that the consent is voluntary. Morse
has remarked that what is "acceptable persuasion" for medically indicated
treatment may be "undue influence" in the experimental phase, but he
qualifies this as outside the usual "physician-patient relationship."'
From the investigator-physician's view this places him in not only a
tenuous position but a vulnerable one as well. Morally, ethically and
scientifically, he behaves as in the customary physician-patient relation-
ship during the course of the experiment but with the realization that he
does so at his own risk. Schreiner has aptly termed this, from "legal
limbo" to "out on a legal limb."8 Most investigators appreciate that
the lack of standards or of accepted or customary practices to be used
as a benchmark in a novel experiment makes the matter of the informed,
voluntary consent by the participant all the more important, since partici-
pant's prior understanding of the risks or hazards that could be reason-
ably foreseen will be significant.' Further, the investigator appreciates
that his action will be measured against other competent investigators in
comparable situations as well as against those legal decisions wherein
informed, voluntary consent was not sought.' 0 When an individual parti-
cipates in an experiment as a normal volunteer or when the experiment
cannot possibly benefit him, there is more opportunity for misunder-
standing and consequent difficulty.
Central to this notion is the fact that some experimentation involving
4. Morse, Legal Implications of Clinical Investigation, 20 Vand. L. Rev. 747 (1967).
5. See Wells v. McGehee, 39 So. 2d 196 (Ct. App. La. 1949); Luka v. Lovrie, 171 Mich.
122, 136 N.W. 1106 (1912). See also Ollet v. Pittsburg, C., C. & St. L. Ry., 201 Pa. 361,
50 A. 1011 (1902).
6. Valentine v. Kaiser Foundation Hosps., 194 Cal. App. 2d 282, 15 Cal. Rptr. 26 (1961);
Yeats v. Hams, 193 Kan. 320, 393 P.2d 982 (1964).
7. Morse, supra note 4, at 749.
8. Schreiner, Liability in Use of Investigational Drugs, 185 J.AX.A. 259, 263 (1963).
9. Natanson v. Kline, 186 Kan. 393, 350 P.2d 1093, aff'd on rehearing, 187 Kan. 186, 354
P.2d 670 (1960).
10. See, e.g., Hyman v. Jewish Chronic Disease Hosp., 21 App. Div. 2d 495, 251
N.Y.S.2d 818 (2d Dep't 1964), rev'd, 15 N.Y.2d 317, 206 N.E.2d 338, 258 N.Y.S.2d 397
(1965).
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humans may not be related to the patient's particular illness; in fact, he
may have no possibility of realizing benefits, direct or indirect. Schreiner
has discussed and categorized the various possibilites within the larger
framework of the evaluation of risk versus benefit for any given study.1
While there is no minimizing that risk versus benefit in human experi-
mentation is a valid consideration, it is beyond the scope of this com-
munication other than to remark that (1) the risk is largely the subject's
but the benefits expected may not necessarily accrue to the particular
subject but to "humanity" or the body discipline of science and (2) when
the putative benefit is said to be important for these latter reasons, it is
essential that both the physician-investigator and the subject have a clear
understanding of all phases of the experiment and that the subject recog-
nizes he will not be benefited except by any feelings of altruism he may
have.
Regardless of the possibility of benefit to the participant, it is sub-
mitted that a valid patient-physician relationship obtains, and thus exist-
ing ethical and legal considerations are germane to the situation. This
notion of combining clinical research with professional care is implicit
in the Declaration of Helsinki and apparently affirmed in litigation.' In
short, the subject has the apppropriate avenues to seek redress for any
real or imagined wrongs suffered during the course of the experimentation.
Being innocent of legal training, yet not inhibited by ignorance (as
bespeaks most scientists), I am persuaded that the tidy virtue of insisting
upon the patient/subject-physician/investigator roles is that common law
and "ethics" are appropriate to any experimental situation wherein the
participating party's consent has been obtained. This posture is adopted
because both law and science are dynamic bodies. It is obvious that
interpretations of law are responsive to current and evolving practices,
customs, mores, attitudes and even social expectations. As scientific knowl-
edge advances, it is inevitable that there will be new situations, new facts
and new experiments as unheard of as organ transplantations were years
ago. It follows that new interpretations will be required and that it is not
possible to anticipate many of the realities of tomorrow. To suggest that
one could accurately predict the nature of medical research would further
suggest the possibility of writing new statutes that by their rigidity
could very likely impede scientific advances. Existing codes such as the
Nuremburg Code, the various Surgeon General's policies and the Decla-
ration of Helsinki of the World Medical Association, recently endorsed by
most of this country's medical and research societies, are useful bench
marks that proscribe the ethics of human experimentation and by their
very existence can be invoked in litigation.1"
11. Schreiner, supra note 8.
12. See Massachusetts Mut. Life Ins. Co. v. Brei, 311 F.2d 463, 469 (2d Cir. 1962).
13. A word of explanation on my own passion for a recognized code of conduct or
guidelines is in order at this point. As the former Director of the Institute of Biomedical
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Before the investigator even solicits participants for his study, it is
necessary that the duly constituted research committee of the involved
institution (and frequently the agency financially supporting the project)
approves and, in effect, endorses the study not only as to its scientific
merits and appropriateness, but as to the foreseeable risks to be borne
by the participants.
Where the subject gives consent for his own participation in experi-
mentation, not only is divulgence of more than the risks and benefits
known by the investigator mandatory, but also I believe it is essential
that the investigator himself, if he is not the patient's own physician,
explain in comprehensible language the appropriate information and
techniques involved in the proposed experiment. This discussion should
be in sufficient detail that the participant has a firm understanding of the
likely course of the experiment, possible discomfort, etc., as well as an
appreciation that a placebo or sham technique may be employed and is
a valid part of a well-designed and properly conducted investigation.
Further, the participant must be made aware that he may terminate his
participation in the experiment at any time consistent with his own
safety. The physician and the research committee of disinterested physi-
cians can make the medical judgements necessary, if the experiments can-
not be stopped immediately without endangering the life of the subject.
The subject must also understand at the beginning of the study whether
the predictable nature of the study might preclude his abrupt withdrawal
and how this matter would be handled should the eventuality arise unex-
pectedly. It seems reasonable for both the participant's and physician's
protection that a signed and/or witnessed instrument attest to this sort
of a consent in most studies."
From the standpoint of making valid scientific observations it is occa-
sionally stated that complete disclosure of the details of certain experi-
Research of the AMA Education and Research Foundation, I began in 1964 to try to
persuade many of the prestigious medical research societies as well as the AMA to formulate
or endorse a meaningful set of guidelines. After several formal meetings and many informal
ones, in the autumn of 1966, the following statement and endorsement of the Declaration
of Helsinki was issued: "We, the undersigned medical organizations, endorse the ethical
principles set forth in the Declaration of Helsinki by the World Medical Association con-
cerning human experimentation. These principles supplement the principles of medical ethics
to which American physicians already subscribe: American Federation for Clinical Research,
American Society for Clinical Investigation, Central Society for Clinical Research, American
College of Physicians, American College of Surgeons, Society for Pediatric Research, Amen-
can Academy of Pediatrics, American Medical Association." I wish to express my deep
appreciation and special thanks to all the officers of the societies and in particular to
Messrs. Bernard Hirsch and Richard Bergen, of the AAL Legal Division, Edwin J. Holman,
Secretary, AMA Judicial Council, Dr. Russell Elkington, Editor of the Annals of Internal
Medicine (of the American College of Physicians), Dr. Oscar Ratnoff of Western Reserve
University School of Medicine and Dr. Howard Frazier of Harvard Medical School for
making this endorsement possible.
14. Written Consent for Clinical Investigation, 276 New Engl. J. Med. US (1967)
(editorial).
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ments would vitiate the experiment's objectives. This factor enters into
drug-trials of mood-affecting agents and many psychological studies. If
common or suspected attitudinal or behavioral responses to a pharmaco-
logic agent or contrived situations are discussed with the participants
and the participants' subjective responses are the prime data to be col-
lected, it is obvious the experiment is not controlled and any results are
open to serious doubt. If it is true that some studies demand that the
human participant be unaware that they are involved in an experiment,
there is a serious problem. Whenever biological variability is probed and
stressed, there is necessarily a risk, large or minute, physiological or
psychological. Whenever individuals are entrapped in experiments, it is
clear that their individual rights have been violated. Whenever agreement
is given to participate in experiments without any information as to their
nature, it is obvious that the participant is not "informed" and a large
measure of faith in the investigator is assumed. Perhaps this is the ulti-
mate limit of the patient-physician relationship, but in this instance,
there may frequently be no disease or condition as the focal point of
interaction, but only the investigator's desire to conduct his studies in
the name of science and whatever personal motivations are operative in
him at the time. Can the compelling abstractions and realities of science,
humanity and the individual rights of both the subject and the investiga-
tor be served in these instances? I do not believe it possible.
There is no doubt that a rigid, literal interpretation of voluntary,
informed consent restricts scientific freedom in some areas, notably
behavioral research. It is obvious too that society has legitimate interests
and needs in many areas of science, just as it does in matters of national
security, public health and welfare. Certainly, public interest compels
society to invade privacy, condemn (and therefore seize) private prop-
erty, and quarantine or institutionalize citizens with certain diseases or
disturbances without consent, yet each situation is weighed and no abso-
lute license to do so exists.
John Stuart Mill has eloquently stated that "over himself, over his own
body and mind, the individual is sovereign,"' 5 but he concluded that
there exists a need for rules of conduct to be imposed "by the law in the
first place, and by opinion on many things which are not fit subjects for
the operation of law. What these rules should be, is the principal ques-
tion in human affairs . . . . ""s What then constitutes the bounds of
decent inquiry, privacy and necessity for research? In a penetrating and
illuminating article, Ruebhausen and Brim suggest that, "[w]hat is
needed is wisdom and restraint, compromise and tolerance, and as whole-
some a respect for the dignity of the individual as the respect accorded
the dignity of science.""
15. J3. Mill, On Liberty 13 (Liberal Arts Press 1956).
16. Id. at 8.
17. Ruebhausen & Brim, Privacy and Behavioral Research, 65 Colum. L. Rev. 1184,
1195 (1965).
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There is another important practical consideration involved in in-
formed consent for human experimentation when the proposed partici-
pant is incompetent by reason of age or mental impairment. The so-called
third party consent is then sought from the parent or legal guardian
which in some circumstances may be the state. For many kinds of bio-
medical studies the populations of institutionalized individuals are an ideal
group for human experimentations. They generally live in a stable environ-
ment and are rwider a fairly rigid control with respect to diet and nutri-
tion, sleep, exercise and environmental exposure. In short, they represent
what the investigator likes to have in his animal rooms and he is reason-
ably sure the animals will be there for some time. Naturally, such human
populations in institutions are not truly random, even if their common
denominator is the absence of both parents.
There are studies, thankfully minuscule in number compared to the
bulk of published. human studies, that have clearly demonstrated a
cavalier disregard for some institutionalized groups of mentally defective
children or a complete indifference to the investigator's first role as a
physician.'8 These studies were authorized by the duly constituted
authorities of the inmate's institution and were said to be proper from
the legal standpoint. It is not certain that they were approved by a re-
search committee of the investigator's institution, but at the time some
of them were conducted, there were not many universities with such
committees. Indeed, there continues today, apart from the granting
agencies' requirement that these committees be constituted, a minority
dissent that these expert and dispassionate committees in some way
abridge academic freedom. However, it is worth noting that academic
freedom has never been a license for irresponsibility. It is a guarantee for
a responsible searching for truth with explicit admonitions to respect the
rights and opinions of others.
It has always seemed cruel and inhumane to regard institutionalized
minors or incompetents as a kind of experimental animal colony where
the investigator is blessed by a stable ecology and captive subjects. I do
not believe the use of these individuals can be rationalized on the grounds
that they "owe" society their participation or because the third party
guardian, frequently the state or other local authority, may be detached
about them. I submit that such individuals should become involved in
experiments only when:
(1) The experiment is relevant (on the basis of available data) to
the condition that caused them to be institutionalized;
(2) A panel of peers responsible to the investigator's institution, unin-
terested in his fortunes and competent in the area of the proposed study
has approved the protocol for the investigation in the same way that NIH
study committees approve grant requests; and,
18. See Beecher, Ethics and Clinical Research, 274 New Engl. J. led. 1354 (1966).
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(3) The details and procedures of the experiment conform to the
principles set forth in the Declaration of Helsinki.
(4) Finally, the legal guardian has given permission on the basis of
the above information.
Such a procedure would not inhibit meaningful investigations and
hopefully might benefit the participants or those like them. It is evident
that it will rule out the use of mentally incompetent children for the
initial testing of some new drugs or immunizing agents having no bearing
on their condition. Surely these and other agents are meant to be used on
other than institutionalized subjects. Non-parametric statistics can be
applied to evaluate studies of the general population, in which all the vari-
ables are not controlled. Surely we as scientists have compassion for our
fellows who are institutionalized.
It should be clearly understood that I have no desire to inhibit or cur-
tail meaningful studies and that the above suggestions are not intended to
preclude children's participation in medical studies. If the "condition"
is age and if neonatal, juvenile, pubertal, etc. conditions are to be in-
vestigated, it is obviously appropriate to study children at these ages. How-
ever, I see no reason to use them as subjects when the condition is not
germane to childhood, and no reason to use mentally incompetent or dis-
turbed individuals unless the condition to be investigated bears on their
state.
It is essential that while humanity and science are served, the individ-
ual's rights must be protected with vigor and vigilance. If this means that
certain experiments cannot be conducted, it is appropriate that they are
not. Medical scientists in the laboratory are privileged to embrace an
operative pragmatism during the continuum of inductive and deductive
reasoning, intuition, imagination and possibly even serendipity that com-
prise the scientific method. Occasionally, the means and the end are
blurred and may even be indistinguishable. In the clinical experiment
with human subjects this facile laboratory stratagem cannot be permitted,
for here the end can never justify the means if human rights and dignity
are violated. There is a special meaning for the scientist in this clich6,
for he above all others exalts in his freedom to seek the truth of life and
he is first a human, then a scientist.
With his customary grace and eloquence, Professor Freund has written:
[M]edicine and law and art have an essential affinity. As the artist himself finds his
freedom in the constraints of his medium, in the canons of taste and in respect for
the limitations of his material, so the judge and the physician too find their freedom
in their fetters, in the symbolic codes that assign them their roles and render it
tolerable to make judgments involving life and death-fetters that somehow make
it possible to surmount the agony and the absurdity of human decisions. 19
19. Freund, Ethical Problems in Human Experimentation, 273 New Engl. J. Med. 687,
692 (1965).
